|
Brentuximab Vedotin
|
D12.776.124.486.485.114.224.060.438 |
|
|
Anesthesia, Obstetrical
|
E03.155.364 |
|
|
Sebaceous Gland Neoplasms
|
C04.588.805.578 |
|
|
Skin Neoplasms
|
C04.588.805 |
|
|
Animal Culling
|
N06.850.780.200.112 |
|
|
Communicable Disease Control
|
N06.850.780.200 |
|
|
Delayed Emergence from Anesthesia
|
D055191 |
[Abnormally slow pace of regaining CONSCIOUSNESS after general anesthesia (ANESTHESIA, GENERAL) usually given during surgical procedures. This condition is characterized by persistent somnolence.
, Postoperative morbidity in patients recovering from general anesthesia where a depressed neuromuscular response due to residual PARESIS continues beyond a defined ANESTHESIA RECOVERY PERIOD.
] |
|
Encephalitis, California
|
C01.207.399.750.300.200 |
|
|
AIDS Arteritis, Central Nervous System
|
C01.221.812.640.400.048 |
|
|
Pectobacterium carotovorum
|
B03.660.250.150.542.120 |
|
|
Pectobacterium
|
B03.660.250.150.542 |
|
|
Sciatic Neuropathy
|
C10.668.829.500.675 |
|
|
Mononeuropathies
|
C10.668.829.500 |
|
|
Glutamyl Aminopeptidase
|
D08.811.277.656.350.555.600 |
|
|
Metalloexopeptidases
|
D08.811.277.656.350.555 |
|
|
Biomarkers, Pharmacological
|
D23.101.137 |
|
|
Lameness, Animal
|
C22.510 |
|
|
Cadherins
|
D23.050.301.350.200 |
|
|
Cell Adhesion Molecules
|
D23.050.301.350 |
|
|
Thymidine Monophosphate
|
D13.695.201.789.788 |
|
